Valuation
- Market cap
- —
- Revenue TTM
- —
- Net income TTM
- —
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- —
- Debt to equity
- —
Trading
- Volume
- 859
- Avg volume
- —
- Day's range
- $65.51 – $65.53
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.
- Phone
- (212) 593-4383
Latest news
No headlines yet.
